However, ex vivo activation of T cells with anti-CD3/anti-CD28/anti-CD2 (α-CD3/CD28/CD2) antibodies led to dose-dependent entry of T cells into MM clusters (Figure 2, B and C). This evidence concerns the gene CD28 and Miyoshi myopathy.